PHLDA3 promotes lung adenocarcinoma cell proliferation and invasion via activation of the Wnt signaling pathway
Authors:
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 101 (9) , 1130-1141
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Wnt Signaling Pathway in Non-Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2013
- Pleckstrin homology (PH) like domains – versatile modules in protein–protein interaction platformsFEBS Letters, 2012
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Updated Staging System for Lung CancerSurgical Oncology Clinics of North America, 2011
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of AktCell, 2009
- Wnt/β-Catenin Signaling in Development and DiseaseCell, 2006
- Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysisThe EMBO Journal, 2005
- Selective Glycogen Synthase Kinase 3 Inhibitors Potentiate Insulin Activation of Glucose Transport and Utilization In Vitro and In VivoDiabetes, 2003
- β‐catenin is a target for the ubiquitin–proteasome pathwayThe EMBO Journal, 1997